Keqian Biotech (688526.SH ): Net profit in 2025 increased by 9.51% year-on-year; proposes a dividend of 6.4 yuan for every 10 shares

NightAirdropper · 2026-04-10T09:26:55+00:00

Gelonghui April 7 — Keqian Biological (688526.SH) released the 2025 annual report showing that the company achieved an operating revenue of 950 million yuan for the year, a year-on-year increase of 0.83%; net profit attributable to shareholders of the parent company was 419 million yuan, a year-on-year increase of 9.51%; non-recurring net profit attributable to shareholders of the parent company was 352 million yuan, a year-on-year increase of 12.74%. A dividend of 6.4 yuan per 10 shares is proposed for all shareholders.

NightAirdropper

2026-04-10 09:26:55

Gelonghui April 7th | Keqian Biology ( 688526.SH ) released the 2025 annual report showing that the company achieved an operating revenue of 950 million yuan for the year, a year-on-year increase of 0.83%; net profit attributable to shareholders of 419 million yuan, a year-on-year increase of 9.51%; and non-recurring net profit attributable to shareholders of 352 million yuan, a year-on-year increase of 12.74%. A cash dividend of 6.4 yuan per 10 shares is proposed to all shareholders.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.